483 related articles for article (PubMed ID: 33147803)
1. Are Heat Shock Proteins an Important Link between Type 2 Diabetes and Alzheimer Disease?
Rowles JE; Keane KN; Gomes Heck T; Cruzat V; Verdile G; Newsholme P
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33147803
[TBL] [Abstract][Full Text] [Related]
2. Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding.
Moreno-Gonzalez I; Edwards Iii G; Salvadores N; Shahnawaz M; Diaz-Espinoza R; Soto C
Mol Psychiatry; 2017 Sep; 22(9):1327-1334. PubMed ID: 28044060
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
[TBL] [Abstract][Full Text] [Related]
4. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of the hetero-assembly of β-amyloid peptide with islet amyloid polypeptide.
Yan LM; Velkova A; Kapurniotu A
Curr Pharm Des; 2014; 20(8):1182-91. PubMed ID: 23713771
[TBL] [Abstract][Full Text] [Related]
7. Catalytic Prion-Like Cross-Talk between a Key Alzheimer's Disease Tau-Fragment R3 and the Type 2 Diabetes Peptide IAPP.
Arya S; Claud SL; Cantrell KL; Bowers MT
ACS Chem Neurosci; 2019 Nov; 10(11):4757-4765. PubMed ID: 31642657
[TBL] [Abstract][Full Text] [Related]
8. Impaired peripheral glucose homeostasis and Alzheimer's disease.
Wijesekara N; Gonçalves RA; De Felice FG; Fraser PE
Neuropharmacology; 2018 Jul; 136(Pt B):172-181. PubMed ID: 29169962
[TBL] [Abstract][Full Text] [Related]
9. Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease.
Wilhelmus MM; de Waal RM; Verbeek MM
Mol Neurobiol; 2007 Jun; 35(3):203-16. PubMed ID: 17917109
[TBL] [Abstract][Full Text] [Related]
10. Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core.
Ge X; Yang Y; Sun Y; Cao W; Ding F
ACS Chem Neurosci; 2018 May; 9(5):967-975. PubMed ID: 29378116
[TBL] [Abstract][Full Text] [Related]
11. Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.
Ashraf GM; Greig NH; Khan TA; Hassan I; Tabrez S; Shakil S; Sheikh IA; Zaidi SK; Akram M; Jabir NR; Firoz CK; Naeem A; Alhazza IM; Damanhouri GA; Kamal MA
CNS Neurol Disord Drug Targets; 2014; 13(7):1280-93. PubMed ID: 25230234
[TBL] [Abstract][Full Text] [Related]
12. Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.
Candeias E; Duarte AI; Sebastião I; Fernandes MA; Plácido AI; Carvalho C; Correia S; Santos RX; Seiça R; Santos MS; Oliveira CR; Moreira PI
Mol Neurobiol; 2017 Oct; 54(8):6471-6489. PubMed ID: 27730513
[TBL] [Abstract][Full Text] [Related]
13. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.
Ramos-Rodriguez JJ; Jimenez-Palomares M; Murillo-Carretero MI; Infante-Garcia C; Berrocoso E; Hernandez-Pacho F; Lechuga-Sancho AM; Cozar-Castellano I; Garcia-Alloza M
Psychoneuroendocrinology; 2015 Dec; 62():69-79. PubMed ID: 26254770
[TBL] [Abstract][Full Text] [Related]
14. Heat-shocked neuronal PC12 cells reveal Alzheimer's disease--associated alterations in amyloid precursor protein and tau.
Johnson G; Refolo LM; Wallace W
Ann N Y Acad Sci; 1993 Sep; 695():194-7. PubMed ID: 8239282
[TBL] [Abstract][Full Text] [Related]
15. Hsp72 (HSPA1A) Prevents Human Islet Amyloid Polypeptide Aggregation and Toxicity: A New Approach for Type 2 Diabetes Treatment.
Rosas PC; Nagaraja GM; Kaur P; Panossian A; Wickman G; Garcia LR; Al-Khamis FA; Asea AA
PLoS One; 2016; 11(3):e0149409. PubMed ID: 26960140
[TBL] [Abstract][Full Text] [Related]
16. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
[TBL] [Abstract][Full Text] [Related]
17. Caveolin: A New Link Between Diabetes and AD.
Surguchov A
Cell Mol Neurobiol; 2020 Oct; 40(7):1059-1066. PubMed ID: 31974905
[TBL] [Abstract][Full Text] [Related]
18. Amylin as a potential link between type 2 diabetes and alzheimer disease.
Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Riverol M; Marcilla I; de Andrea CE; Sánchez-Arias JA; Del Mar Carmona-Abellan M; Marti G; Erro ME; Martínez-Vila E; Tuñon MT; Luquin MR
Ann Neurol; 2019 Oct; 86(4):539-551. PubMed ID: 31376172
[TBL] [Abstract][Full Text] [Related]
19. Interplay between Alzheimer's disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic tissue and serum in APP/PS1 transgenic mice.
Liu X; Wang W; Chen HL; Zhang HY; Zhang NX
Acta Pharmacol Sin; 2019 Oct; 40(10):1259-1268. PubMed ID: 31089202
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
